Issue 20, May 20, 2014

Each Tuesday, to enhance awareness of emerging scientific knowledge, selected science clips will be posted here for the public health community. The focus is applied public health research and prevention science that has the capacity to improve health now.

1. Key Scientific Articles in Featured Topic Areas
   Subject matter experts decide what topic to feature, and articles are selected from the last 3 to 6 months of published literature. Key topic coincides monthly with other CDC products (e.g. Vital Signs).
   • Communicable Diseases - HIV Pre-exposure Prophylaxis
     1. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
        Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, McMahan V, et al..
        Sci Transl Med. 2012 Sep 12;4(151):151ra125.
        
     2. Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus
        Andrews CD, Spreen WR, Mohri H, Moss L, Ford S, Gettie A, Russell-Lodrigue K, et al..
        Science. 2014 Mar 7;343(6175):1151-4.
        
     3. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
        Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, et al..
        N Engl J Med. 2012 Aug 2;367(5):399-410.
        
     4. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
        Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, et al..
        Lancet. 2013 Jun 15;381(9883):2083-90.
        
     5. State adolescent consent laws and implications for HIV pre-exposure prophylaxis
        Culp L, Caucci L.
        Am J Prev Med. 2013 Jan;44(1 Suppl 2):S119-24.
        
     6. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection
        Garcia-Lerma JG, Cong ME, Mitchell J, Youngpairoj AS, Zheng Q, Masciotra S, Martin A, et al..
        Sci Transl Med. 2010 Jan 13;2(14):14ra4.
        
     7. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
        Garcia-Lerma JG, Otten RA, Qari SH, Jackson E, Cong ME, Masciotra S, et al..
        PLoS Med. 2008 Feb;5(2):e28.
        
     8. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies
        Gomez GB, Borquez A, Case KK, Wheelock A, Vassall A, Hankins C.
        PLoS Med. 2013 ;10(3):e1001401.
        
     9. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
        Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, et al..
        N Engl J Med. 2010 Dec 30;363(27):2587-99.
        
     10. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States
         Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, Collins BM, et al..
         J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):79-86.
         
     11. Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design
         Hendrix CW.
         Cell. 2013 Oct 24;155(3):515-8.
         
     12. Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials
         Jiang J, Yang X, Ye L, Zhou B, Ning C, Huang J, Liang B, et al..
         PLoS One. 2014 ;9(2):e87674.
         
     13. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies
         Koenig LJ, Lyles C, Smith DK.
         Am J Prev Med. 2013 Jan;44(1 Suppl 2):S91-8.
         
     14. HIV-1 drug resistance in the iPrEx Pre-Exposure Prophylaxis Trial
         Liegler T, Abdel-Mohsen M, Bentley LG, Atchison R, Schmidt T, Javier J, Mehrotra M, et al..
         J Infect Dis. 2014 Apr 16.
         
     15. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
         Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, Colfax G, et al..
         J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):87-94.
         
     16. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis
         Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, McMahan V, et al..
         PLoS One. 2013 ;8(12):e81997.
         
     17. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission
         Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, Cohen MS, Kashuba AD.
         Sci Transl Med. 2011 Dec 7;3(112):112re4.
         
     18. Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen
         Radzio J, Aung W, Holder A, Martin A, Sweeney E, Mitchell J, Bachman S, et al..
         PLoS One. 2012 ;7(12):e50632.
         
     19. Preexposure prophylaxis for the prevention of HIV infection in the United States 2014 - clinical providers' supplement
         U.S. Public Health Service.
         . 2014 .
         
     20. Preexposure prophylaxis for the prevention of HIV infection in the United States 2014 - a clinical practice guideline
         U.S. Public Health Service.
         . 2014 .
         
     21. Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States
         Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW.
         J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):421-7.
         
     22. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana
         Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, et al..
         N Engl J Med. 2012 Aug 2;367(5):423-34.
         
     23. Preexposure prophylaxis for HIV infection among African women
         Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, et al..
         N Engl J Med. 2012 Aug 2;367(5):411-22.
         
   
   
2. CDC Authored Publications
   The names of CDC authors are indicated in bold text.
   Articles published in the past 6-8 weeks authored by CDC or ATSDR staff.
   • Chronic Diseases and Conditions
     24. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity
         Cohen BL, Zoega H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE.
         Aliment Pharmacol Ther. 2014 Apr;39(8):811-22.
         
     25. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States
         Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER.
         Emerg Infect Dis. 2014 May;20(5):822-8.
         
     26. Disability in U.S. households, 2000-2010: findings from the National Health Interview Survey
         Altman BM, Blackwell DL.
         Fam Relat. 2014 Feb;63(1):20-38.
         
     27. Chronic fatigue syndrome: the current status and future potentials of emerging biomarkers
         Fischer DB, William AH, Strauss AC, Unger ER, Jason LA, Marshall Jr GD, Dimitrakoff JD.
         Fatigue. 2014 April;2(2):93-109.
         
     28. Meeting the information needs of lower income cancer survivors: results of a randomized control trial evaluating the American Cancer Society's "I Can Cope"
         Martin MY, Evans MB, Kratt P, Pollack LA, Smith JL, Oster R, Dignan M, Prayor-Patterson H, Watson C, Houston P, Andrews S, Liwo A, Tseng TS, Hullett S, Oliver J, Pisu M.
         J Health Commun. 2014 Apr;19(4):441-59.
         
     29. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
         Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T, Liese AD, Merchant AT, Lawrence JM, Reynolds K, Dolan L, Liu LL, Hamman RF.
         JAMA. 2014 May 7;311(17):1778-86.
         
   • Communicable Diseases
     30. HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies
         Lasry A, Sansom SL, Wolitski RJ, Green TA, Borkowf CB, Patel P, Mermin J.
         AIDS. 2014 May 6.
         
     31. Estimating per-act HIV transmission risk: a systematic review
         Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J.
         AIDS. 2014 May 6.
         
     32. Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok
         Thienkrua W, Todd CS, Chaikummao S, Sukwicha W, Yafant S, Tippanont N, Varangrat A, Khlaimanee P, Holtz TH.
         AIDS Care. 2014 May 6:1-11.
         
     33. Hepatitis B virus infection testing and prevalence among Asian and Pacific Islanders
         Vijayadeva V, Spradling PR, Moorman AC, Rupp LB, Mei L, Gordon SC, Henkle E, Boscarino JA, Teshale EH, Nakasato C.
         Am J Manag Care. 2014 Apr 17;20(4):e98-e104.
         
     34. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population
         Gordon SC, Lamerato LE, Rupp LB, Li J, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Henkle EM, Oja-Tebbe N, Lu M.
         Clin Gastroenterol Hepatol. 2014 May;12(5):885-93.
         
     35. Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013
         Pabbaraju K, Tellier R, Wong S, Li Y, Bastien N, Tang JW, Drews SJ, Jang Y, Davis CT, Fonseca K, Tipples GA.
         Emerg Infect Dis. 2014 May;20(5).
         
     36. Influenza-associated hospitalizations and deaths, Costa Rica, 2009-2012
         Saborio GG, Clara A, Garcia A, Quesada F, Palekar R, Minaya P, Cervantes M, Lopez M, Lara J, Jara J, Blanco N, Bresee J, Widdowson MA, Azziz-Baumgartner E.
         Emerg Infect Dis. 2014 May;20(5):878-81.
         
     37. Correlates of prevalent sexually transmitted infections among participants screened for an HIV incidence cohort study in Kisumu, Kenya
         Otieno FO, Ndivo R, Oswago S, Pals S, Chen R, Thomas T, Kunneke E, Mills LA, McLellan-Lemal E.
         Int J STD AIDS. 2014 May 8.
         
     38. Hepatitis C disease burden and strategies to manage the burden
         Dore GJ, Ward J, Thursz M.
         J Viral Hepat. 2014 May;21 Suppl 1:1-4.
         
     39. Early identification and linkage to care of persons with chronic hepatitis B virus infection - three U.S. sites, 2012-2014
         Beckett GA, Ramirez G, Vanderhoff A, Nichols K, Chute SM, Wyles DL, Schoenbachler BT, Bedell DT, Cabra R, Ward JW.
         MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):399-401.
         
     40. Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model - Arizona and Utah, 2012-2014
         Mitruka K, Thornton K, Cusick S, Orme C, Moore A, Manch RA, Box T, Carroll C, Holtzman D, Ward JW.
         MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):393-8.
         
     41. Primary and secondary syphilis - United States, 2005-2013
         Patton ME, Su JR, Nelson R, Weinstock H.
         MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):402-6.
         
   • Community Health Services
     42. Travel to Brazil: analysis of data from the Boston Area Travel Medicine Network (BATMN) and relevance to travelers attending World Cup and Olympics
         Iliaki E, Chen LH, Hamer DH, Macleod WB, Jentes ES, Barnett ED, Wilson ME.
         J Travel Med. 2014 May;21(3):214-7.
         
     43. Implications of the fast-evolving scale-up of adult voluntary medical male circumcision for quality of services in South Africa
         Rech D, Spyrelis A, Frade S, Perry L, Farrell M, Fertziger R, Toledo C, Castor D, Njeuhmeli E, Loykissoonlal D, Bertrand JT.
         PLoS One. 2014 May 6;9(5):e80577.
         
   • Disease Reservoirs and Vectors
     44. Estimation of insecticide persistence, biological activity and mosquito resistance to PermaNet(R) 2 long-lasting insecticidal nets over three to 32 months of use in Ethiopia
         Anshebo GY, Graves PM, Smith SC, Wills AB, Damte M, Endeshaw T, Shargie EB, Gebre T, Mosher AW, Patterson AE, Emerson PM.
         Malar J. 2014 Mar 6;13(1):80.
         
   • Drug Safety
     45. Risk of adverse health outcomes with increasing duration and regularity of opioid therapy
         Paulozzi LJ, Zhang K, Jones CM, Mack KA.
         J Am Board Fam Med. 2014 May-Jun;27(3):329-38.
         
   • Environmental Health
     46. Indoor exposure to particulate matter and age at first acute lower respiratory infection in a low-income urban community in Bangladesh
         Gurley ES, Salje H, Homaira N, Ram PK, Haque R, Petri WA, Bresee J, Moss WJ, Luby SP, Breysse P, Azziz-Baumgartner E.
         Am J Epidemiol. 2014 Apr 15;179(8):967-73.
         
     47. Efficacy of chlorine dioxide tablets on inactivation of Cryptosporidium oocysts
         Murphy JL, Haas CN, Arrowood MJ, Hlavsa MC, Beach MJ, Hill VR.
         Environ Sci Technol. 2014 May 5.
         
     48. Perfluorooctanoate exposure and major birth defects
         Stein CR, Savitz DA, Elston B, Thorpe PG, Gilboa SM.
         Reprod Toxicol. 2014 May 3.
         
   • Health Disparities
     49. Kidney transplantation and the intensity of poverty in the contiguous United States
         Mohan S, Mutell R, Patzer RE, Holt J, Cohen D, McClellan W.
         Transplantation. 2014 May 7.
         
   • Healthcare Associated Infections
     50. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature
         Le M, Ravin K, Hasan A, Clauss H, Muchant DG, Pasko JK, Cipollina G, Abanyie F, Montgomery SP, Loy M, Ahmed M, Mathur M, Chokkalingam Mani B, Mehr J, Kotru A, Varma C, Maksimak M, Schultz M, Obradovic G, Alvarez R, Toyoda Y, Birkenbach M, Brunner E, Nelson J.
         Am J Transplant. 2014 May;14(5):1199-206.
         
     51. Acinetobacter bacteraemia in Thailand: evidence for infections outside the hospital setting
         Porter KA, Rhodes J, Dejsirilert S, Henchaichon S, Siludjai D, Thamthitiwat S, Prapasiri P, Jorakate P, Kaewpan A, Peruski LF, Kerdsin A, Prasert K, Yuenprakone S, Maloney SA, Baggett HC.
         Epidemiol Infect. 2014 Jun;142(6):1317-27.
         
     52. A new approach to mitigate biofilm formation on totally implantable venous access ports
         Donlan RM.
         J Infect Dis. 2014 May 1.
         
   • Immunity and Immunization
     53. Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007-08 through 2011-12 seasons
         Lu PJ, O'Halloran A, Bryan L, Kennedy ED, Ding H, Graitcer SB, Santibanez TA, Meghani A, Singleton JA.
         Am J Infect Control. 2014 May 2.
         
     54. Influenza seasonality: timing and formulation of vaccines
         Cox N.
         Bull World Health Organ. 2014 May;92(5):311-311.
         
     55. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine prevented influenza associated hospitalizations in older adults
         Fry AM, Kim IK, Reed C, Thompson M, Chaves SS, Finelli L, Bresee J.
         Clin Infect Dis. 2014 May 6.
         
     56. Non dermatomal rash and pancytopenia in a 5 year old child
         Khandelwal P, Marsh R, Schmid DS, Folster J, Radford KW, Davies SM, Filipovich A.
         J Clin Virol. 2014 Apr 13.
         
     57. Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data
         Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, Perea W, Ferguson NM.
         PLoS Med. 2014 May;11(5):e1001638.
         
     58. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care
         Zimmerman RK, Nowalk MP, Lin CJ, Hannibal K, Moehling KK, Huang HH, Matambanadzo A, Troy J, Allred NJ, Gallik G, Reis EC.
         Vaccine. 2014 Apr 29.
         
   • Laboratory Sciences
     59. Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda
         Nankoberanyi S, Mbogo GW, LeClair NP, Conrad MD, Tumwebaze P, Tukwasibwe S, Kamya MR, Tappero J, Nsobya SL, Rosenthal PJ.
         Malar J. 2014 Mar 14;13(1):95.
         
   • Mining
     60. The equivalence of the ray tracing and modal methods for modeling radio propagation in lossy rectangular tunnels
         Zhou C, Waynert J.
         IEEE Antennas Wirel Propag Lett. 2014 Mar 21;13:615-618.
         
   • Nutritional Sciences
     61. Development and use of the generic WHO/CDC logic model for vitamin and mineral interventions in public health programmes
         De-Regil LM, Pena-Rosas JP, Flores-Ayala R, del Socorro Jefferds ME.
         Public Health Nutr. 2014 Mar;17(3):634-9.
         
   • Occupational Safety and Health
     62. Occupational fatalities among driver/sales workers and truck drivers in the United States, 2003-2008
         Chen GX, Amandus HE, Wu N.
         Am J Ind Med. 2014 May 8.
         
     63. Measurement of mass-based carbon nanotube penetration through filtering facepiece respirator filtering media
         Vo E, Zhuang Z, Birch E, Zhao Q, Horvatin M, Liu Y.
         Ann Occup Hyg. 2014 May 6.
         
     64. Urinary polycyclic aromatic hydrocarbon (OH-PAH) metabolite concentrations and the effect of GST polymorphisms among US Air Force personnel exposed to jet fuel
         Rodrigues EG, Smith K, Maule AL, Sjodin A, Li Z, Romanoff L, Kelsey K, Proctor S, McClean MD.
         J Occup Environ Med. 2014 May;56(5):465-71.
         
     65. Interactive effects of cerium oxide and diesel exhaust nanoparticles on inducing pulmonary fibrosis
         Ma JY, Young SH, Mercer RR, Barger M, Schwegler-Berry D, Ma JK, Castranova V.
         Toxicol Appl Pharmacol. 2014 May 2.
         
     66. Toluene diisocyanate (TDI) disposition and co-localization of immune cells in hair follicles
         Nayak AP, Hettick JM, Siegel PD, Anderson SE, Long CM, Green BJ, Beezhold DH.
         Toxicol Sci. 2014 May 6.
         
   • Parasitic Diseases
     67. Neglected parasitic infections in the United States: cysticercosis
         Cantey PT, Coyle CM, Sorvillo FJ, Wilkins PP, Starr MC, Nash TE.
         Am J Trop Med Hyg. 2014 May;90(5):805-9.
         
     68. Neglected parasitic infections in the United States: toxoplasmosis
         Jones JL, Parise ME, Fiore AE.
         Am J Trop Med Hyg. 2014 May;90(5):794-9.
         
     69. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high Malaria transmission setting in Uganda
         Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine FN, Nsobya SL, Conrad MD, Arinaitwe E, Kamya M, Tappero J, Staedke SG, Dorsey G, Greenhouse B, Rosenthal PJ.
         Am J Trop Med Hyg. 2014 May 5.
         
     70. Neglected parasitic infections in the United States: Chagas disease
         Montgomery SP, Starr MC, Cantey PT, Edwards MS, Meymandi SK.
         Am J Trop Med Hyg. 2014 May;90(5):814-8.
         
     71. Neglected parasitic infections in the United States: trichomoniasis
         Secor WE, Meites E, Starr MC, Workowski KA.
         Am J Trop Med Hyg. 2014 May;90(5):800-4.
         
     72. Neglected parasitic infections in the United States: toxocariasis
         Woodhall DM, Eberhard ML, Parise ME.
         Am J Trop Med Hyg. 2014 May;90(5):810-3.
         
     73. A description of malaria sentinel surveillance: a case study in Oromia Regional State, Ethiopia
         Yukich JO, Butts J, Miles M, Berhane Y, Nahusenay H, Malone JL, Dissanayake G, Reithinger R, Keating J.
         Malar J. 2014 Mar 11;13(1):88.
         
   • Physical Activity
     74. Vital Signs: disability and physical activity - United States, 2009-2012
         Carroll DD, Courtney-Long EA, Stevens AC, Sloan ML, Lullo C, Visser SN, Fox MH, Armour BS, Campbell VA, Brown DR, Dorn JM.
         MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):407-13.
         
   • Statistics as Topic
     75. Combining information from two data sources with misreporting and incompleteness to assess hospice-use among cancer patients: a multiple imputation approach
         He Y, Landrum MB, Zaslavsky AM.
         Stat Med. 2014 May 7.
         
     76. Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit
         Wiegand RE, Rose CE, Karon JM.
         Stat Methods Med Res. 2014 May 5.
         
   • Substance Use and Abuse
     77. Exposure to secondhand smoke and attitudes toward smoke-free workplaces among employed U.S. adults: findings from the National Adult Tobacco Survey
         King BA, Homa DM, Dube SR, Babb SD.
         Nicotine Tob Res. 2014 May 8.
         
     78. Association between current asthma and secondhand smoke exposure in vehicles among adults living in four US states
         Nguyen KH, King BA, Dube SR.
         Tob Control. 2014 May 2.
         
   • Veterinary Medicine
     79. Feline fecal virome reveals novel and prevalent enteric viruses
         Ng TF, Mesquita JR, Nascimento MS, Kondov NO, Wong W, Reuter G, Knowles NJ, Vega E, Esona MD, Deng X, Vinje J, Delwart E.
         Vet Microbiol. 2014 Apr 13.
         
   • Zoonoses
     80. Francisella tularensis subsp. tularensis group A.I, United States
         Birdsell DN, Johansson A, Ohrman C, Kaufman E, Molins C, Pearson T, Gyuranecz M, Naumann A, Vogler AJ, Myrtennas K, Larsson P, Forsman M, Sjodin A, Gillece JD, Schupp J, Petersen JM, Keim P, Wagner DM.
         Emerg Infect Dis. 2014 May;20(5).
         
     81. Erythema multiforme after orf virus infection: a report of two cases and literature review
         Joseph RH, Haddad FA, Matthews AL, Maroufi A, Monroe B, Reynolds M.
         Epidemiol Infect. 2014 May 8:1-6.
         
     82. Sylvatic typhus associated with flying squirrels (Glaucomys volans) in New York State, United States
         Prusinski MA, White JL, Wong SJ, Conlon MA, Egan C, Kelly-Cirino CD, Laniewicz BR, Backenson PB, Nicholson WL, Eremeeva ME, Karpathy SE, Dasch GA, White DJ.
         Vector Borne Zoonotic Dis. 2014 Apr;14(4):240-4.
         
     83. Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcRIIA-mediated antibody-dependent enhancement of infection
         Chotiwan N, Roehrig JT, Schlesinger JJ, Blair CD, Huang CY.
         Virology. 2014 May;456-457(1):238-246.
         
   
   

Back to Top

____

DISCLAIMER: Articles listed in the CDC Science Clips are selected by the Stephen B. Thacker CDC Library to provide current awareness of the public health literature. An article's inclusion does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.